V Assmann

Summary

Affiliation: Imperial Cancer Research Fund
Country: UK

Publications

  1. ncbi request reprint The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells
    V Assmann
    Richard Dimbleby Department of Cancer Research ICRF Laboratory, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    J Cell Sci 111:1685-94. 1998
  2. ncbi request reprint The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
    V Assmann
    Richard Dimbleby Department of Cancer Research ICRF Laboratory, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    J Cell Sci 112:3943-54. 1999
  3. ncbi request reprint The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells
    V Assmann
    Richard Dimbleby Department of Cancer Research/Imperial Cancer Research Fund Laboratory, St. Thomas' Hospital, London SE1 7EH, UK
    J Pathol 195:191-6. 2001
  4. ncbi request reprint Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein
    M Hofmann
    Forschungszentrum Karlsruhe, Institute of Genetics, D 76021 Karlsruhe, Germany
    J Cell Sci 111:1673-84. 1998
  5. ncbi request reprint CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation
    T Ahrens
    Department of Dermatology, University of Freiburg, Freiburg, Germany
    J Invest Dermatol 116:93-101. 2001
  6. ncbi request reprint Problems with RHAMM: a new link between surface adhesion and oncogenesis?
    M Hofmann
    Forschungszentrum Karlsruhe and University of Karlsruhe, Institutes of Genetics, Germany
    Cell 95:591-2; author reply 592-3. 1998

Collaborators

Detail Information

Publications6

  1. ncbi request reprint The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells
    V Assmann
    Richard Dimbleby Department of Cancer Research ICRF Laboratory, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    J Cell Sci 111:1685-94. 1998
    ....
  2. ncbi request reprint The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments
    V Assmann
    Richard Dimbleby Department of Cancer Research ICRF Laboratory, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    J Cell Sci 112:3943-54. 1999
    ....
  3. ncbi request reprint The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells
    V Assmann
    Richard Dimbleby Department of Cancer Research/Imperial Cancer Research Fund Laboratory, St. Thomas' Hospital, London SE1 7EH, UK
    J Pathol 195:191-6. 2001
    ..017). These results suggest that RHAMM/IHABP expression may contribute to the motility and invasiveness of a tumour cell sub-population in breast cancers...
  4. ncbi request reprint Identification of IHABP, a 95 kDa intracellular hyaluronate binding protein
    M Hofmann
    Forschungszentrum Karlsruhe, Institute of Genetics, D 76021 Karlsruhe, Germany
    J Cell Sci 111:1673-84. 1998
    ..Clearly, the sequence we have identified encodes a protein with properties substantially different to the RHAMM protein. We tentatively name the protein intracellular hyaluronic acid binding protein, IHABP...
  5. ncbi request reprint CD44 is the principal mediator of hyaluronic-acid-induced melanoma cell proliferation
    T Ahrens
    Department of Dermatology, University of Freiburg, Freiburg, Germany
    J Invest Dermatol 116:93-101. 2001
    ....
  6. ncbi request reprint Problems with RHAMM: a new link between surface adhesion and oncogenesis?
    M Hofmann
    Forschungszentrum Karlsruhe and University of Karlsruhe, Institutes of Genetics, Germany
    Cell 95:591-2; author reply 592-3. 1998